Biodegradable particles as vaccine delivery systems: size matters

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Poly(lactide-co-glycolide) (PLGA) particles are promising for antigen delivery.
• Particle size significantly influences the immune response to vaccination.

Purpose of the Study:

• To investigate the impact of PLGA particle size on antigen delivery and immune stimulation.
• To characterize PLGA particles loaded with ovalbumin (OVA) and CpG oligodeoxynucleotides (CpG ODN).

Main Methods:

• Fabrication and characterization of PLGA particles in various sizes (17 μm, 7 μm, 1 μm, 300 nm).
• In vitro assessment of dendritic cell uptake and activation.
• In vivo vaccination studies in C57BL/6 mice with two intraperitoneal injections.

Main Results:

• PLGA particle size influenced drug release kinetics.
• 300 nm PLGA particles exhibited highest dendritic cell internalization and activation.
• Vaccination with 300 nm PLGA particles induced superior antigen-specific cytotoxic T cell responses and a higher IgG2a:IgG1 antibody ratio.

Conclusions:

• Smaller PLGA particle size (300 nm) enhances antigen-specific cytotoxic T cell responses.
• Optimal PLGA particle size is crucial for effective antigen and adjuvant delivery systems.